ELVN (STOCKS)
Enliven Therapeutics, Inc. Common Stock
$39.330000
+0.050000 (+0.13%)
Prev close: $39.280000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Richard A. Fair
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,881.74M
- Employees
- 63
- P/E (TTM)
- -23.54
- P/B (TTM)
- 3.21
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
11
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.49 | $-0.41 | -0.0838 | -20.63% |
|
Mar 2026 (Q1)
|
$-0.38 | $-0.47 | +0.0920 | +19.49% |
|
Dec 2025 (Q4)
|
$-0.48 | $-0.39 | -0.0947 | -24.58% |
|
Sep 2025 (Q3)
|
$-0.32 | $-0.44 | +0.1224 | +27.67% |